|
1
|
Bubendorf L, Schopfer A, Wagner U, Sauter
G, Moch H, Willi N, Gasser TC and Mihatsch MJ: Metastatic patterns
of prostate cancer: An autopsy study of 1589 patients. Hum Pathol.
31:578–583. 2000.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Varkarakis MJ, Winterberger AR, Gaeta J,
Moore RH and Murphy GP: Lung metastases in prostatic carcinoma.
Clinical significance. Urology. 3:447–452. 1974.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Fabozzi SJ, Schellhammer PF and El-Mahdi
AM: Pulmonary metastases from prostate cancer. Cancer.
75:2706–2709. 1995.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Rockey KE and Graham TE: Prostate
adenocarcinoma metastatic to the lung. Postgrad Med. 87:199–205.
1990.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Smith CP, Sharma A, Ayala G, Cagle P and
Kadmon D: Solitary pulmonary metastasis from prostate cancer. J
Urol. 162(2102)1999.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hofland CA and Bagg MD: An isolated
pulmonary metastasis in prostate cancer. Mil Med. 165:973–974.
2000.PubMed/NCBI
|
|
7
|
Chao DH, Higgins JP and Brooks JD:
Biochemical remission after resection of prostate cancer lung
metastasis. Urology. 63:584–585. 2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Pruthi RS, Hubbard JS, Kouba E and Wallen
E: Androgen-independent prostate cancer treated with resection of
the solitary metastatic site. Urol Int. 79:371–373. 2007.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Khandani AH, Funkhouser WK, Feins R and
Socinski MA: Simultaneous FDG PET +/Glut1+ lung and FDG
PET-/Glut1-subcarinal lymph node metastases from prostate cancer.
Ann Nucl Med. 23:595–597. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Boyer BP and Boyer MJ: An elusive tumor in
a man who has evidence of prostate cancer metastasis. JAAPA.
22:22–25. 2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sakai T, Kimura D, Hatanaka R, Yamada Y,
Tsushima T, Fukuda I and Kamata Yl: Surgical treated pulmonary
metastasis from prostatic cancer: Report of a case. Kyobu Geka.
63:340–343. 2010.PubMed/NCBI(In Japanese).
|
|
12
|
Goto T, Maeshima A, Oyamada Y and Kato R:
Solitary pulmonary metastasis from prostate sarcomatoid cancer.
World J Surg Oncol. 8(101)2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Pepe P, Fraggetta F, Tornabene F, Nicolosi
M and Aragona F: Solitary lung metastasis after radical
prostatectomy in presence of undetectable PSA. Arch Ital Urol
Androl. 84:208–210. 2010.PubMed/NCBI
|
|
14
|
Calais J, Lussato D, Menard J, Kerviler
ED, Mongiat-Artus P, Castier Y and Merlet P: Resection of a
solitary pulmonary metastasis from prostatic Adenocarcinoma
misdiagnosed as a Bronchocele: Usefulness of 18F-choline and
18F-FDG PET/CT. J Thorac Oncol. 12:1826–1829. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Maebayashi T, Abe K, Aizawa T, Sakaguchi
M, Ishibashi N, Fukushima S, Honma T, Kusumi Y, Matsui T and Kawata
N: Solitary pulmonary metastasis from prostate cancer with
neuroendocrine differentiation: A case report and review of
relevant cases from the literature. World J Surg Oncol. 13:173–180.
2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Gago JP, Câmara G, Dionísio J and Opinião
A: Pulmonary metastasis as sole manifestation of relapse in
previously treated localized prostate cancer: Three exceptional
case reports. Ecancermedicalscience. 10(645)2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Mortier D, Baten E, Vandeurzen K and van
Renterghem K: The benefit of a surgical resection of a solitary
pulmonary metastasis of prostate cancer after radical
prostatectomy. Curr Urol. 20:210–212. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Iijima Y, Kinoshita H, Nakajima Y, Akiyama
H, Uramoto H and Hirata T: Isolated solitary lung metastasis 12
years after radical prostatectomy for prostate cancer without
elevation of the serum prostate-specific antigen level. Jpn J Chest
Surg. 31:648–652. 2017.(In Japanese).
|
|
19
|
Rush J, Pai R and Parikh RA: Complete
biochemical response after pulmonary metastasectomy in prostate
adenocarcinoma. Exp Hematol Oncol. 6(25)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hokamp NG, Kobe C, Linzenich E, Maintz D
and Drzezga A: Solitary PSMA-positive pulmonary metastasis in
biochemical relapse of prostate cancer. Clin Nucl Med. 42:406–407.
2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Boschian R, Rizzo M, Zandona L, Trombetta
C and Liguori G: Pulmonary recurrence from prostate cancer and
biochemical remission after metastasis directed therapy. A case
report. Arch Ital Urol Androl. 90:74–75. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Polverari G, Ceci F, Allen-Auerbach M,
Gupta P, Fishbein MC, Reiter RE, Lee JM, Hope TA, Carroll RM,
Czernin J and Calais J: Solitary mucinous prostate adenocarcinoma
lung metastasis detected by 68Ga-PSMA-11 PET/CT. Clin
Genitourin Cancer. 17:e53–e55. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Asano H, Arakawa S, Kato D, Mori S, Nakada
T and Ohtsuka T: A case of single lung metastasis with normal serum
PSA level after prostate cancer surgery. Jpn Chest Surg. 33:66–69.
2019.(In Japanese).
|
|
24
|
Wu LX, Lei L, Zhu YC, Du KQ, Li XF, Chen
HF, Wang WX and Xu CW: A prostate cancer patient with isolated lung
metastases: A case report. Transl Cancer Res. 9:2064–2068.
2020.
|
|
25
|
Yoshitake H, Oura S, Yamaguchi T and
Makimoto S: Solitary lung metastasis of prostate cancer with a long
disease-free interval and normal prostate-specific antigen level.
Case Rep Oncol. 14:284–289. 2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Heidenreich A, Bastian PJ, Bellmunt J,
Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T,
Zattoni F, et al: EAU guidelines on prostate cancer. Part II:
Treatment of advanced, relapsing, and castration-resistant prostate
cancer. Eur Urol. 65:467–479. 2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Tourinho-Barbosa R, Srougi V, Nunes-Silva
I, Baghdadi M, Rembeyo G, Eiffel SS, Barret E, Rozet F, Galiano M,
Cathelineau X and Sanchez-Salas R: Biochemical recurrence after
radical prostatectomy: What does it mean? Int Braz J Urol.
44:14–21. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Leibovici D, Spiess PE, Agarwal PK, Tu SM,
Pettaway CA, Hitszhusen K, Millikan RE and Pisters L: Prostate
cancer progression in the presence of undetectable or low serum
prostate-specific antigen level. Cancer. 109:198–204.
2007.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Copeland JN, Amin BD, Humphrey PA, Tamboli
P, Ro JY and Gal AA: The morphologic spectrum of metastatic
prostatic adenocarcinoma to the lung. Am J Clin Pathol.
117:552–557. 2002.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Onaitis MW, Petersen RP, Haney JC, Salts
L, Park B, Flores R, Rizk N, Bains MS, Dycoco J, D'Amico TA, et al:
Prognostic factors for recurrence after pulmonary resection of
colorectal cancer metastases. Ann Thorac Surg. 87:1684–1688.
2009.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yamamoto K, Yoshikawa H, Shiromizu K,
Saito T, Kuzuya K, Tsunematsu R and Kamura T: Pulmonary
metastasectomy for uterine cervical cancer: A multivariate
analysis. Ann Thorac Surg. 77:1179–1182. 2004.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ost P, Decaestecker K, Lambert B, Fonteyne
V, Delrue L, Lumen N, Ameye F and De Meerleer G: Prognostic factors
influencing prostate cancer-specific survival in non-castrate
patients with metastatic prostate cancer. Prostate. 74:297–305.
2014.PubMed/NCBI View Article : Google Scholar
|
